219 related articles for article (PubMed ID: 21425543)
1. [Current management of myelodysplastic syndromes].
Vey N; Charbonnier A
Rev Prat; 2010 Dec; 60(10):1416-9. PubMed ID: 21425543
[TBL] [Abstract][Full Text] [Related]
2. Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
Cazzola M
Int J Hematol; 2000 Aug; 72(2):134-8. PubMed ID: 11039660
[TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.
Beran M
Int J Hematol; 2000 Aug; 72(2):139-50. PubMed ID: 11039661
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
Malcovati L
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S305-11. PubMed ID: 19778858
[TBL] [Abstract][Full Text] [Related]
5. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
[TBL] [Abstract][Full Text] [Related]
6. How to treat MDS without stem cell transplantation.
Gattermann N
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S30-6. PubMed ID: 19857591
[TBL] [Abstract][Full Text] [Related]
7. Supportive care including growth factors in myelodysplastic syndromes.
Gardin C; Fenaux P
Rev Clin Exp Hematol; 2004 Dec; 8(2):E3. PubMed ID: 16027101
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
9. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
Alessandrino EP; Amadori S; Barosi G; Cazzola M; Grossi A; Liberato LN; Locatelli F; Marchetti M; Morra E; Rebulla P; Visani G; Tura S;
Haematologica; 2002 Dec; 87(12):1286-306. PubMed ID: 12495903
[TBL] [Abstract][Full Text] [Related]
10. The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines.
Greenberg PL; Cosler LE; Ferro SA; Lyman GH
J Natl Compr Canc Netw; 2008 Oct; 6(9):942-53. PubMed ID: 18926103
[TBL] [Abstract][Full Text] [Related]
11. Advances in supportive care of myelodysplastic syndromes.
Gordon MS
Semin Hematol; 1999 Oct; 36(4 Suppl 6):21-4. PubMed ID: 10530713
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
Jabbour E; Kantarjian HM; Koller C; Taher A
Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes: a challenging disease for patients and physicians.
Somani N
J Assoc Physicians India; 2012 Feb; 60():107-8, 113. PubMed ID: 22715557
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplasia: when to treat and how.
Larson RA
Best Pract Res Clin Haematol; 2006; 19(2):293-300. PubMed ID: 16516126
[TBL] [Abstract][Full Text] [Related]
15. Strategies for achieving transfusion independence in myelodysplastic syndromes.
Thomas ML
Eur J Oncol Nurs; 2007 Apr; 11(2):151-8. PubMed ID: 16935559
[TBL] [Abstract][Full Text] [Related]
16. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life.
Balducci L
Cancer; 2006 May; 106(10):2087-94. PubMed ID: 16607649
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and therapy of myelodysplastic syndromes in Germany: a retrospective multicenter analysis.
Gattermann N; Kündgen A; Kellermann L; Zeffel M; Paessens B; Germing U
Onkologie; 2012; 35(6):350-6. PubMed ID: 22722455
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes: biology and treatment.
Jädersten M; Hellström-Lindberg E
J Intern Med; 2009 Mar; 265(3):307-28. PubMed ID: 19141095
[TBL] [Abstract][Full Text] [Related]
20. New Approaches to Myelodysplastic Syndrome Treatment.
Bazinet A; Bravo GM
Curr Treat Options Oncol; 2022 May; 23(5):668-687. PubMed ID: 35320468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]